Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 17, 1993 - Issue 5
24
Views
9
CrossRef citations to date
0
Altmetric
Original Article

HB Melusine [α114(GH2)PRO→SER]: A New Neutral Hemoglobin Variant

, , , , &
Pages 397-405 | Received 05 Feb 1993, Accepted 17 Jun 1993, Published online: 07 Jul 2009
 

Abstract

Hb Melusine [α114(GH2)Pro→Ser] was found in an Algerian patient during a systematic screening for hemoglobinopathies performed in Luxembourg. The abnormal hemoglobin was suspected when a thickening of the Hb A band was observed by isoelectrofocusing. The mutant hemoglobin was silent in all other electrophoretic methods used for presumptive diagnosis with the exception of globin electrophoresis in the presence of Triton X-100. This technique revealed an α chain considerably more hydrophobic than normal. The structural abnormality of Hb Melusine concerns position α114(GH2) that belongs to a cluster of hydrophobic residues localized in the N-terminal half of the αT-12b tryptic peptide. It has been shown in the case of another variant of that position (Hb Nouakchott), that the replacement of the Pro GH2 by a Leu was responsible for a dramatic increase in the retention time of the a polypeptide chain during reversed phase high performance liquid chromatography, much higher than that reported for similar substitutions in other regions of the hemoglobin molecule.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.